03/23/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/23/2020. This 12-page document aims to support public health preparedness planning and response activities based upon social distancing measures aimed at minimizing the spread of COVID-19 (coronavirus). Updates include additional information about workplace closures; discussion of the term social distancing vis-à-vis the practice of physical distancing; and discussion of the importance of promoting solidarity and mutual community support when social distancing measures are implemented. (PDF)
03/23/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/23/2020. This four-page document aims to support public health preparedness planning and response activities on the safe handling of bodies of deceased persons with suspected or confirmed COVID-19 (coronavirus): at the site of death; during transport, storage, and preparation before burial/cremation; and during burial/cremation. There is no evidence so far of transmission of SARS-CoV-2 through the handling of bodies of deceased persons. (PDF)
03/22/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 3/22/2020. The World Health Organization has outlined critical priority actions for preparedness, readiness, and response actions for COVID-19 (coronavirus) and has defined four transmission scenarios. This six-page document provides guidance to policymakers and laboratories on testing strategies for each of these four scenarios, including the scenario in which testing can be performed only on a limited number of patients. (PDF)
03/22/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/22/2020. This guidance is intended to provide key actions that local and state health departments, homelessness service systems, housing authorities, emergency planners, healthcare facilities, and homeless outreach services can take to protect people experiencing homelessness from the spread of COVID-19 (coronavirus). (Text)
03/21/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 3/21/2020. In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats. This four-page publication provides feedback on questions about necessary data elements, sources of data, gaps in collection, and suggestions for data system design and integration to improve modeling and decision-making for COVID-19 (coronavirus). The standing committee includes approximately 15 members with expertise in emerging infectious diseases, public health, public health preparedness and response, biological sciences, clinical care and crisis standards of care, risk communication, and regulatory issues. (Text)
03/21/2020 12:00 AM EDT
Source: U.S. Department of Housing and Urban Development (HUD). Published: 3/21/2020. This four-page document offers information to help Continuum of Care (CoC) and Homeless Management Information Systems (HMIS) leadership at the local level to create an action plan for recording and communicating data around COVID-19 (coronavirus) and homelessness for their community. HUD strongly recommends that CoCs work with their local health departments to blend their activities and actions with the plans the health departments are activating. (PDF)
03/20/2020 12:00 AM EDT
Source: U.S. Department of Health and Human Services (HHS). Published: 3/20/2020. This web page, updated on March 20, 2020, addresses the release of protected health information for planning or response activities in emergency situations, and discusses the Privacy Rule, which protects individually identifiable health information from uses and disclosures that unnecessarily compromise the privacy of an individual. It provides additional information about planning, response, and waivers, including the waiving of potential HIPAA penalties for good faith use of telehealth during the nationwide public health emergency due to COVID-19. (Text)
03/20/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/20/2020. This 13-page guidance communicates the Food and Drug Administration's policy for the temporary preparation of certain alcohol-based hand sanitizer products by firms that register as over-the-counter (OTC) drug manufacturers to prepare alcohol-based hand sanitizers during the COVID-19 (coronavirus) pandemic. It outlines that the agency does not intend to take action against manufacturing firms that prepare alcohol-based hand sanitizers for consumer use and for use as health care personnel hand rubs during this ongoing public health emergency as described in the guidance. (PDF)
03/20/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/20/2020. This 11-page guidance communicates the Food and Drug Administration's policy for the temporary compounding of certain alcohol-based hand sanitizer products by pharmacists in state-licensed pharmacies or federal facilities and registered outsourcing facilities (referred to collectively in this guidance as compounders) for the duration of the public health emergency for COVID-19 (coronavirus). (PDF)
03/20/2020 12:00 AM EDT
Source: Evidence Aid. Published: 3/20/2020. This web page provides summaries of relevant research about the COVID-19 (coronavirus) pandemic that are available as soon as each is ready. Research categories are clinical characterization and management; health systems and services; and infection prevention and control, including health care workers’ protection. (Text)
03/20/2020 12:00 AM EDT
Source: United Nations Children's Fund (UNICEF). Published: 3/20/2020. The purpose of this 12-page document, published with the World Health Organization and International Federation of Red Cross and Red Crescent Societies, is to provide clear and actionable guidance for safe operations through the prevention, early detection, and control of COVID-19 (coronavirus) in schools and other educational facilities. The guidance, while specific to countries that have already confirmed the transmission of COVID-19, is still relevant in all other contexts. (PDF)
03/20/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/20/2020. This 10-page document aims to provide a risk assessment and management options for the safe and sustainable supply of substances of human origin (SoHO) to assist the European Union/European Economic Area (EU/EEA) Member States in responding to the threat posed by the coronavirus disease 2019 (COVID-19) pandemic. Following the rapid spread of COVID-19 in the EU/EEA and worldwide, the European Centre for Disease Prevention and Control (ECDC) has published a set of rapid risk assessments and set out measures on how to maintain the safety and sustainability of SoHO supply. (Presentation Slides)
03/20/2020 12:00 AM EDT
Source: National Library of Medicine [National Institutes of Health] (NLM). Published: 3/20/2020. This interim guidance reviews special considerations for persons with HIV and their health care providers in the United States regarding COVID-19 (coronavirus). This guidance includes general information to consider, and provides guidance for special populations, persons with HIV in quarantine or isolation, and clinicians. (Text)
03/20/2020 12:00 AM EDT
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 3/20/2020. This two-page document details the steps to take for opioid treatment programs (OTPs) for patients quarantined at home with COVID-19 (coronavirus). OTPs should obtain documentation now for each patient as to who is designated permission to pick up medication for them and maintain the process of determining a designee for any new patients. (PDF)
03/19/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/19/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ePlex SARS-CoV-2 Test, which received an Emergency Use Authorization from the Food and Drug Administration on March 19, 2020. The ePlex SARS-CoV-2 Test is authorized for use on using respiratory specimens collected from individuals suspected of COVID-19 (coronvrius) by their health care provider. (PDF)
03/19/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/19/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Simplexa COVID-19 Direct assay , which received an Emergency Use Authorization from the Food and Drug Administration on March 19, 2020. The Simplexa COVID-19 Direct assay is authorized for use on using respiratory specimens collected from individuals suspected of COVID-19 (coronavirus) by their healthcare provider. (PDF)
03/19/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/19/2020. While every community is unique and experiencing varying levels of community transmission of COVID-19 (coronavirus), the 15-day pause presents the entire country with an opportunity to assess how prepared communities are, and to take steps to implement actions designed to slow and limit the spread of COVID-19. This web page details steps every sector can take during the 15-day pause to plan as One Community, and the need to coordinate a community-wide strategy. (Text)
03/19/2020 12:00 AM EDT
Source: U.S. Department of Homeland Security (DHS). Published: 3/19/2020. This 11-page guidance and accompanying list are intended to support state, local, and industry partners in identifying the 16 critical infrastructure sectors and the essential workers needed to maintain the services and functions Americans depend on daily and that need to be able to operate resiliently during the COVID-19 (coronavirus) pandemic response. Promoting the ability of such workers to continue to work during periods of community restriction, access management, social distancing, or closure orders/directives is crucial to community resilience and continuity of essential functions. The Healthcare/Public Health Sector is one of the critical infrastructure sectors. (PDF)
03/19/2020 12:00 AM EDT
Source: Association of State and Territorial Health Officials (ASTHO). Published: 3/19/2020. This two-page document summarizes recent guidance for providing medication-assisted treatment (MAT) for opioid use disorder during the COVID-19 (coronavirus) outbreak. It describes significant action that has already been taken at the federal level to ease restrictions on and encourage continuity of care for patients receiving medication-assisted treatment. (PDF)
03/19/2020 12:00 AM EDT
Source: Association of State and Territorial Health Officials (ASTHO). Published: 3/19/2020. This two-page document describes several state and federal level actions that have been implemented to support the homeless population by providing guidance to shelters, housing advocacy groups, and healthcare professionals on how to mitigate the spread of COVID-19 (coronavirus). It discusses considerations and provides additional resources. (PDF)
03/19/2020 12:00 AM EDT
Source: National Center for Disaster Preparedness [Columbia University, Earth Institute] (NCDP). Published: 3/19/2020. In response to COVID-19 (coronavirus), many organizations have been thrust into response mode developing and implementing continuity of operations policies and procedures on-the-fly. This one-hour, 16-minute webinar provides a formal introduction to Continuity of Operations Planning (COOP) specifically for child-serving and community-based organizations. The principles presented in this training can be applied to the current environment as well as for formal planning process. (Video or Multimedia)
03/19/2020 12:00 AM EDT
Source: International Association of Emergency Managers (IAEM). Published: 3/19/2020. This one-hour, 20-minute webinar, cosponsored with the International Association of Emergency Managers Canada and the Centre for Crisis & Risk Communication, provides information about how organizations might apply science-based risk communication tools to their response to pandemic events such as COVID-19 (coronavirus). Crisis and risk communication professionals discuss types of coronavirus, lessons learned from the SARS pandemic, and crisis decision-making. (Video or Multimedia)
03/19/2020 12:00 AM EDT
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 3/19/2020. The COVID-19 (coronavirus) epidemic has created countless primary and secondary challenges for those delivering care to the most vulnerable populations. An additional concern has arisen for those with alcohol use disorder, benzodiazepine use disorder, or other conditions that increase the risk of seizures. This five-page document offers precautionary guidance to those that are prepared and capable to receive and treat these individuals. (PDF)
03/19/2020 12:00 AM EDT
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 3/19/2020. This two-page document provides answers to frequently asked questions about providing methadone and buprenorphine for the treatment of opioid use disorder during the COVID-19 (coronavirus) epidemic. Topics include the use of telehealth for new and existing patients, and dispensing medication based on telehealth. (PDF)
03/19/2020 12:00 AM EDT
Source: Minnesota Department of Health. Published: 3/19/2020. This 14-minute video provides the healthcare responder with just-in-time training on responder stress during the COVID-19 (coronavirus) epidemic, and provides stress management strategies that should be implemented now to protect the healthcare workforce. (Video or Multimedia)
03/19/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 3/19/2020. This eight-page document is intended for health ministers, health system administrators, and other decision-makers to guide the care of COVID-19 (coronavirus) patients as the response capacity of health systems is challenged; and to ensure that COVID-19 patients can access life-saving treatment, without compromising public health objectives and safety of health workers. (PDF)
03/19/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/19/2020. This 30-minute conference call provides a situational update of the COVID-19 (coronavirus) epidemic for Centers for Disease Control and Prevention (CDC) partners, including members of the private sector, public health organizations, universities, and clinical societies. The speaker answers questions related to social distancing, the epidemiology curve of this pandemic, whether or not people should wear masks, and other topics. (Video or Multimedia)
03/18/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/18/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Abbott RealTime SARS-CoV-2 assay, which received an Emergency Use Authorization from the Food and Drug Administration on March 18, 2020. The Abbott RealTime SARS-CoV-2 assay is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 (coronavirus) by their healthcare provider. (PDF)
03/18/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 3/18/2020. During this special 58-minute webinar from the Emergency Partners Information Connection (EPIC), Dr. Jay Butler shares the current state of the COVID-19 (coronavirus) outbreak, what the Centers for Disease Control and Prevention (CDC) is doing to respond to the outbreak, and how partners, organizations, and the public can help. He responds to 20 questions about COVID-19, including about transmission, travel, and mass gatherings. (Video or Multimedia)
03/18/2020 12:00 AM EDT
Source: American Association of Blood Banks (AABB). Published: 3/18/2020. This 10-page toolkit was updated to align with the Food and Drug Administration (FDA)’s Updated Information for Blood Establishments Regarding the Novel Coronavirus Outbreak, and continues to provide information on the optional precautionary measures which are not regulatory requirements. It has been updated to assist blood establishments by highlighting new information and changes; and to offer “Notes to consider” as blood establishments evaluate the considerations, and address concerns with community spread of the virus and its impact on blood availability. (PDF)
03/18/2020 12:00 AM EDT
Source: Association of State and Territorial Health Officials (ASTHO). Published: 3/18/2020. This two-page document discusses how, with increased efforts to advance community mitigation of COVID-19 (coronavirus), public health and healthcare sectors should consider utilizing or leveraging telehealth services. It provides examples of state and federal actions to expand telehealth services. (PDF)
03/18/2020 12:00 AM EDT
Source: American Society for Transplantation and Cellular Therapy (ASTCT). Published: 3/18/2020. This 12-page document is intended as a guide for diagnosis and management of COVID-19 (caused by the virus SARS-CoV-2) in adult and pediatric hematopoietic cell transplant (HCT) and cellular therapy patients. There is currently limited data on the epidemiology and clinical manifestations of COVID-19 in this population. Specific practices may vary depending on local epidemiology and testing capacity. (PDF)
03/18/2020 12:00 AM EDT
Source: Overseas Development Institute (ODI). Published: 3/18/2020. This one-hour, 34-minute webinar discusses to what degree the lessons learned from the West Africa Ebola outbreak have been taken into account in the Democratic Republic of the Congo (DRC) Ebola response and how barriers to containment of the disease could be better addressed. The response to Ebola in the DRC has been complicated by conflict between central government, local political actors, and armed groups in the affected areas. (Video or Multimedia)
03/18/2020 12:00 AM EDT
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 3/18/2020. Individuals with serious mental illness are at particular risk related to co-occurring medical conditions, as well as challenges with accessing healthcare. This two-page document details how attention to proper prevention and infection control procedures, as well as attention to the psychological impacts of COVID-19 (coronavirus), are important for mental health facilities. (PDF)
03/18/2020 12:00 AM EDT
Source: Ohio Department of Health. Published: 3/18/2020. The frequently asked questions about COVID-19 (coronavirus) and opioid treatment programs in this six-page document have been reviewed and cleared by the Substance Abuse and Mental Health Services Administration (SAMHSA). States and programs are encouraged to review the information, developed to support opioid treatment programs relating to the COVID-19 situation in Ohio, for potential consideration and application to their individual circumstances. (PDF)
03/18/2020 12:00 AM EDT
Source: American Society of Health-Systems Pharmacists (ASHP). Published: 3/18/2020. This eight-page tool is intended to assist in COVID-19 (coronavirus) pandemic planning efforts in departments of pharmacy and to foster pharmacist involvement in preparedness at the institutional and community levels. This tool is not intended to cover all pandemic planning, but is intended to be useful in identifying gaps and vulnerabilities in a pharmacy department’s readiness for the COVID-19 pandemic. (PDF)
03/17/2020 12:00 AM EDT
Source: Henry J. Kaiser Family Foundation. Published: 3/17/2020. To inform discussions about the challenges associated with coronavirus (COVID-19) in the U.S., this report analyzed data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS) to estimate the total number of adults nationwide, and by state, who have an elevated risk of serious illness if they are infected with coronavirus. Older people and younger adults with serious medical conditions, such as heart disease, diabetes, and lung disease, have a greater risk of becoming severely ill if they get infected with coronavirus. (PDF)
03/17/2020 12:00 AM EDT
Source: Johns Hopkins University, Bloomberg School of Public Health. Published: 3/17/2020. In this 31-minute presentation, experts from the Johns Hopkins Bloomberg School of Public Health address questions about the COVID-19 (coronavirus) epidemic that include: What actions do we know are effective in pandemics? Does social distancing truly make a difference in an outbreak? What have we learned about COVID-19 that can inform how we prepare and respond in our daily lives? (Video or Multimedia)
03/17/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/17/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Quest Diagnostics SARS-CoV-2 RNA, Qualitative Real-Time RT-PCR (Quest SARS-CoV-2 rRT-PCR) test, which received an Emergency Use Authorization from the Food and Drug Administration on March 17, 2020. The Quest SARS-CoV-2 rRT-PCR test is authorized for use on respiratory specimens from individuals suspected of COVID-19 (coronavirus) by their healthcare provider. (PDF)
03/17/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 3/17/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Lyra SARS-CoV-2 Assay, which received an Emergency Use Authorization from the Food and Drug Administration on March 17, 2020. The Lyra SARS-CoV-2 Assay is authorized for use on respiratory specimens from individuals suspected of COVID-19 (coronavirus) by their healthcare provider. (PDF)
03/17/2020 12:00 AM EDT
Source: Infectious Diseases Society of America (IDSA). Published: 3/17/2020. Given current limited availability of near-patient, or point-of-care, testing for COVID-19 (coronavirus), these recommendations were developed for diagnostic testing prioritization in four tiers. These recommendations will likely change as testing becomes more widely available or as new information becomes available. (PDF)
03/17/2020 12:00 AM EDT
Source: Henry J. Kaiser Family Foundation. Published: 3/17/2020. This issue brief summarizes what is known thus far about pregnancy and COVID-19 (coronavirus). A chart details how during the COVID-19 pandemic, many pregnancy-related services could be delivered via telemedicine, and the document discusses how there are a number of specific reasons why pregnant women may be uniquely affected by the COVID-19 pandemic, but information is limited currently. (Text)
03/17/2020 12:00 AM EDT
Source: Child Care Aware of America. Published: 3/17/2020. In this 54-minute webinar, speakers share the latest coronavirus (COVID-19) and emergency preparedness resources from Child Care Aware of America, updates and advice from staff, and work that the Maryland Child Care Resource Network is doing to assist the child care community and families in Maryland. The webinar also includes a discussion of what’s being done around the country at child care agencies and what people are doing to prepare and work with families. (Video or Multimedia)
03/15/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 3/15/2020. In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats. This one-page letter provides feedback on questions about the survival of COVID-19 (coronavirus) on surfaces and the incubation period between exposure and onset of symptoms. The standing committee includes approximately 15 members with expertise in emerging infectious diseases, public health, public health preparedness and response, biological sciences, clinical care and crisis standards of care, risk communication, and regulatory issues. (Text)
03/14/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 3/14/2020. In response to a request from the Office of Science and Technology Policy (OSTP), the National Academies of Sciences, Engineering, and Medicine convened a standing committee of experts to help inform OSTP on critical science and policy issues related to emerging infectious diseases and other public health threats. This two-page letter provides feedback on questions about severe illness in younger adults in Italy infected with COVID-19 (coronavirus). The standing committee includes approximately 15 members with expertise in emerging infectious diseases, public health, public health preparedness and response, biological sciences, clinical care and crisis standards of care, risk communication, and regulatory issues. (Text)
03/10/2020 12:00 AM EDT
Source: U.S. Department of Housing and Urban Development (HUD). Published: 3/10/2020. The emergence of the coronavirus (COVID-19) calls for enhanced cooperation between public health authorities, homeless service systems, and other partners at the local level. This one-hour, 17-minute webinar features a panel of experts who provide the most up-to-date information available and identify resources to support local response efforts by homeless assistance providers and their partners. (Video or Multimedia)
03/06/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 3/6/2020. This guidance provides recommendations on the cleaning and disinfection of households where persons under investigation (PUI) or those with confirmed COVID-19 (coronavirus) reside or may be in self-isolation. They are aimed at limiting the survival of the virus in the environments. These recommendations will be updated if additional information becomes available. The guidelines are focused on household settings and are meant for the general public. (Text)
03/06/2020 12:00 AM EST
Source: American Association of Blood Banks (AABB). Published: 3/6/2020. In the event of an infectious disease outbreak (i.e., influenza, coronavirus [COVID-19]), blood centers and transfusion services must have robust strategies to help protect the health and safety of both staff and donors. This 10-page document provides guidance for planning and preparation, which are critical to limit the potential negative impact of COVID-19 on health care and the blood supply. Effective communication, current information, and education are key to successful strategies. (Text)
03/01/2020 12:00 AM EST
Source: U.S. Department of Health and Human Services (HHS). Published: 3/2020. In response to the nationwide emergency concerning COVID-19 (coronavirus), the U.S. Department of Health and Human Services (HHS) has exercised the authority to waive sanctions and penalties against a covered hospital that does not comply with the provisions of the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule detailed in this five-page memorandum. The waiver became effective on March 15, 2020. (PDF)
11/01/2019 12:00 AM EDT
Source: National Center for Disaster Preparedness [Columbia University, Earth Institute] (NCDP). Published: 11/2019. This Continuity of Operations Planning (COOP) training package, developed with Save the Children, will help ensure that critical services, organizational functions, and programs remain operational or are restored as soon as possible after a disaster or emergent event. These tools will help an organization create or update its Continuity of Operations Plan. Materials include a Plan Template, COOP Facilitator’s Guide, and Essential Functions Worksheet and Table. (Text)
01/01/2019 12:00 AM EST
Source: World Health Organization, Regional Office for Europe. Published: 2019. By bringing together in one place the latest evidence and analyzing the different facets of the complex problem of tackling antimicrobial resistance (AMR), this 274-page book, the first in a new joint series between the European Observatory on Health Systems and Policies and Cambridge University Press, offers an accessible summary for policy-makers, academics, and students on the big questions around AMR policy. (PDF)
01/01/2019 12:00 AM EST
Source: World Health Organization, Regional Office for Europe. Published: 2019. This 38-page policy brief, published with the European Observatory on Health Systems and Policies, summarizes some of the key policy avenues for tackling antimicrobial resistance (AMR). Following the widely accepted One Health approach to combating AMR, the brief aims to support the implementation of national action plans on AMR, drawing on numerous examples of effective policies implemented by European Union Member States and involving the human, animal, and environmental health sectors. (PDF)
.png)
No hay comentarios:
Publicar un comentario